ASO Visual Abstract: Mutational Status is Associated with Higher Rate of Pathologic Complete Response After Neoadjuvant Chemotherapy in Hormone Receptor-Positive Breast Cancer

被引:0
|
作者
Myers, Sara P. [1 ,2 ]
Sevilimedu, Varadan [3 ]
Barrio, Andrea V.
Tadros, Audree B. [1 ]
Mamtani, Anita [1 ]
Robson, Mark E. [4 ]
Morrow, Monica [1 ]
Lee, Minna K. [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Surg, Breast Serv, New York, NY 11553 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Med, Breast Med Serv, New York, NY USA
[3] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, Biostat Serv, New York, NY USA
[4] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY USA
关键词
D O I
10.1245/s10434-023-14390-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:8469 / 8470
页数:2
相关论文
共 50 条
  • [21] Hormone receptor status and pathologic response of HER2-positive breast cancer treated with neoadjuvant chemotherapy and trastuzumab
    Peintinger, F.
    Buzdar, A. U.
    Kuerer, H. M.
    Mejia, J. A.
    Hatzis, C.
    Gonzalez-Angulo, A. M.
    Pusztai, L.
    Esteva, F. J.
    Dawood, S. S.
    Green, M. C.
    Hortobagyi, G. N.
    Symmans, W. F.
    ANNALS OF ONCOLOGY, 2008, 19 (12) : 2020 - 2025
  • [22] Impact of progesterone receptor status on response to neoadjuvant chemotherapy in estrogen receptor-positive breast cancer patients
    Boland, Michael R.
    Ryan, Eanna J.
    Nugent, Timothy
    Gilroy, Darina
    Kelly, Michael E.
    Kennedy, John
    Maguire, Aoife
    Alazawi, Dhafir
    Boyle, Terence J.
    Connolly, Elizabeth M.
    JOURNAL OF SURGICAL ONCOLOGY, 2020, 122 (05) : 861 - 868
  • [23] ASO Visual Abstract: Effect of Age on Outcomes After Neoadjuvant Chemotherapy for Breast Cancer
    Verdial, Francys C.
    Mamtani, Anita
    Pawloski, Kate R.
    Sevilimedu, Varadan
    D'Alfonso, Timothy M.
    Zhang, Hong
    Gemignani, Mary L.
    Barrio, Andrea, V
    Morrow, Monica
    Tadros, Audree B.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (06) : 3820 - 3821
  • [24] ASO Visual Abstract: Effect of Age on Outcomes After Neoadjuvant Chemotherapy for Breast Cancer
    Francys C. Verdial
    Anita Mamtani
    Kate R. Pawloski
    Varadan Sevilimedu
    Timothy M. D’Alfonso
    Hong Zhang
    Mary L. Gemignani
    Andrea V. Barrio
    Monica Morrow
    Audree B. Tadros
    Annals of Surgical Oncology, 2022, 29 : 3820 - 3821
  • [25] Neoadjuvant Endocrine Therapy as an Alternative to Neoadjuvant Chemotherapy Among Hormone Receptor-Positive Breast Cancer Patients: Pathologic and Surgical Outcomes
    Cao, Lifen
    Sugumar, Kavin
    Simpson, Ashley
    Rock, Lisa
    Li, Pamela
    Freyvogel, Mary
    Dietz, Jill
    Montero, Alberto Jose
    Shenk, Robert
    Miller, Megan E.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 2) : S243 - S244
  • [26] Neoadjuvant Endocrine Therapy as an Alternative to Neoadjuvant Chemotherapy Among Hormone Receptor-Positive Breast Cancer Patients: Pathologic and Surgical Outcomes
    Cao, Lifen
    Sugumar, Kavin
    Keller, Eleanor
    Li, Pamela
    Rock, Lisa
    Simpson, Ashley
    Freyvogel, Mary
    Montero, Alberto J.
    Shenk, Robert
    Miller, Megan E.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (10) : 5730 - 5741
  • [27] Neoadjuvant Endocrine Therapy as an Alternative to Neoadjuvant Chemotherapy Among Hormone Receptor-Positive Breast Cancer Patients: Pathologic and Surgical Outcomes
    Lifen Cao
    Kavin Sugumar
    Eleanor Keller
    Pamela Li
    Lisa Rock
    Ashley Simpson
    Mary Freyvogel
    Alberto J. Montero
    Robert Shenk
    Megan E. Miller
    Annals of Surgical Oncology, 2021, 28 : 5730 - 5741
  • [28] ASO Visual Abstract: Immunohistochemical Status Predicts Pathologic Complete Response to Neoadjuvant Therapy in HER2 Overexpressing Breast Cancers
    Winer, Leah
    Ruth, Karen J.
    Bleicher, Richard J.
    Nagarathinam, Rajeswari
    McShane, Melissa
    Porpiglia, Andrea S.
    Pronovost, Mary T.
    Aggon, Allison
    Williams, Austin D.
    ANNALS OF SURGICAL ONCOLOGY, 2025, 32 (02) : 979 - 980
  • [29] Exploring the influencing factors of the pathologic complete response in estrogen receptor-positive, HER2-negative breast cancer after neoadjuvant chemotherapy: a retrospective study
    Tang, Lingfeng
    Shu, Xiujie
    Tu, Gang
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2022, 20 (01)
  • [30] Exploring the influencing factors of the pathologic complete response in estrogen receptor-positive, HER2-negative breast cancer after neoadjuvant chemotherapy: a retrospective study
    Lingfeng Tang
    Xiujie Shu
    Gang Tu
    World Journal of Surgical Oncology, 20